Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
2
XAIR Quote, Financials, Valuation and Earnings
Last price:
$0.74
Seasonality move
:
-13.13%
Day range:
$0.69 - $0.75
52-week range:
$0.67 - $10.40
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.25x
P/B ratio:
0.26x
Volume:
154.5K
Avg. volume:
126K
1-year change:
-89.87%
Market cap:
$3.4M
Revenue:
$3.7M
EPS (TTM):
-$7.53
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
XAIR
Beyond Air, Inc.
|
$2.1M | -$0.25 | 243.81% | -8.29% | $10.33 |
|
IVF
INVO Fertility, Inc.
|
$1.9M | -- | -8.8% | -- | -- |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$2.7M | -- | -54.48% | -57.14% | $2.30 |
|
NTRB
Nutriband, Inc.
|
$675K | -$0.17 | 4.52% | -54.85% | $15.00 |
|
NVNO
enVVeno Medical Corp.
|
-- | -$0.28 | -- | -9.68% | $12.50 |
|
SINT
SINTX Technologies, Inc.
|
$300K | -$0.55 | -44.65% | -56.43% | $12.25 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
XAIR
Beyond Air, Inc.
|
$0.73 | $10.33 | $3.4M | -- | $0.00 | 0% | 3.25x |
|
IVF
INVO Fertility, Inc.
|
$0.75 | -- | $11.4M | -- | $0.00 | 0% | 0.02x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$0.76 | $2.30 | $38.2M | -- | $0.00 | 0% | 2.52x |
|
NTRB
Nutriband, Inc.
|
$4.54 | $15.00 | $55.2M | -- | $0.00 | 0% | 22.65x |
|
NVNO
enVVeno Medical Corp.
|
$0.32 | $12.50 | $6.5M | -- | $0.00 | 0% | 473.07x |
|
SINT
SINTX Technologies, Inc.
|
$3.86 | $12.25 | $14.9M | -- | $0.00 | 0% | 6.55x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
XAIR
Beyond Air, Inc.
|
48.09% | 1.518 | 106.48% | 2.68x |
|
IVF
INVO Fertility, Inc.
|
41.99% | 0.410 | 10.12% | 0.07x |
|
NMTC
NeuroOne Medical Technologies Corp.
|
3.64% | 3.209 | 0.6% | 3.40x |
|
NTRB
Nutriband, Inc.
|
3.31% | 3.036 | 0.32% | 7.07x |
|
NVNO
enVVeno Medical Corp.
|
2.62% | 2.708 | 4.32% | 12.90x |
|
SINT
SINTX Technologies, Inc.
|
45.47% | 0.781 | 22.94% | 1.47x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
XAIR
Beyond Air, Inc.
|
-$298K | -$7.7M | -126.53% | -220.61% | -421.4% | -$4.7M |
|
IVF
INVO Fertility, Inc.
|
$492.6K | -$1.6M | -188.23% | -471.28% | -93.08% | -$1.8M |
|
NMTC
NeuroOne Medical Technologies Corp.
|
$1.5M | -$1.4M | -83.42% | -89.54% | -50.02% | -$1.5M |
|
NTRB
Nutriband, Inc.
|
$63K | -$3.9M | -159.71% | -164.64% | -1121.15% | -$1.8M |
|
NVNO
enVVeno Medical Corp.
|
-$120K | -$4.9M | -56.26% | -57.7% | -- | -$4.4M |
|
SINT
SINTX Technologies, Inc.
|
-$66K | -$3.4M | -115.95% | -208.36% | -1612.98% | -$2.6M |
Beyond Air, Inc. vs. Competitors
-
Which has Higher Returns XAIR or IVF?
INVO Fertility, Inc. has a net margin of -454.24% compared to Beyond Air, Inc.'s net margin of -150.51%. Beyond Air, Inc.'s return on equity of -220.61% beat INVO Fertility, Inc.'s return on equity of -471.28%.
Company Gross Margin Earnings Per Share Invested Capital XAIRBeyond Air, Inc.-16.39% -$1.25 $24.9M IVFINVO Fertility, Inc.28.04% -$6.14 $10.1M -
What do Analysts Say About XAIR or IVF?
Beyond Air, Inc. has a consensus price target of $10.33, signalling upside risk potential of 1323.32%. On the other hand INVO Fertility, Inc. has an analysts' consensus of -- which suggests that it could grow by 19033.67%. Given that INVO Fertility, Inc. has higher upside potential than Beyond Air, Inc., analysts believe INVO Fertility, Inc. is more attractive than Beyond Air, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XAIRBeyond Air, Inc.2 1 0 IVFINVO Fertility, Inc.0 0 0 -
Is XAIR or IVF More Risky?
Beyond Air, Inc. has a beta of 0.341, which suggesting that the stock is 65.907% less volatile than S&P 500. In comparison INVO Fertility, Inc. has a beta of 2.606, suggesting its more volatile than the S&P 500 by 160.551%.
-
Which is a Better Dividend Stock XAIR or IVF?
Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. INVO Fertility, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. INVO Fertility, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XAIR or IVF?
Beyond Air, Inc. quarterly revenues are $1.8M, which are larger than INVO Fertility, Inc. quarterly revenues of $1.8M. Beyond Air, Inc.'s net income of -$8.3M is lower than INVO Fertility, Inc.'s net income of -$2.6M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while INVO Fertility, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 3.25x versus 0.02x for INVO Fertility, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XAIRBeyond Air, Inc.3.25x -- $1.8M -$8.3M IVFINVO Fertility, Inc.0.02x -- $1.8M -$2.6M
-
Which has Higher Returns XAIR or NMTC?
NeuroOne Medical Technologies Corp. has a net margin of -454.24% compared to Beyond Air, Inc.'s net margin of -59.08%. Beyond Air, Inc.'s return on equity of -220.61% beat NeuroOne Medical Technologies Corp.'s return on equity of -89.54%.
Company Gross Margin Earnings Per Share Invested Capital XAIRBeyond Air, Inc.-16.39% -$1.25 $24.9M NMTCNeuroOne Medical Technologies Corp.55.77% -$0.03 $7.3M -
What do Analysts Say About XAIR or NMTC?
Beyond Air, Inc. has a consensus price target of $10.33, signalling upside risk potential of 1323.32%. On the other hand NeuroOne Medical Technologies Corp. has an analysts' consensus of $2.30 which suggests that it could grow by 203.43%. Given that Beyond Air, Inc. has higher upside potential than NeuroOne Medical Technologies Corp., analysts believe Beyond Air, Inc. is more attractive than NeuroOne Medical Technologies Corp..
Company Buy Ratings Hold Ratings Sell Ratings XAIRBeyond Air, Inc.2 1 0 NMTCNeuroOne Medical Technologies Corp.1 0 0 -
Is XAIR or NMTC More Risky?
Beyond Air, Inc. has a beta of 0.341, which suggesting that the stock is 65.907% less volatile than S&P 500. In comparison NeuroOne Medical Technologies Corp. has a beta of 0.575, suggesting its less volatile than the S&P 500 by 42.534%.
-
Which is a Better Dividend Stock XAIR or NMTC?
Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeuroOne Medical Technologies Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. NeuroOne Medical Technologies Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XAIR or NMTC?
Beyond Air, Inc. quarterly revenues are $1.8M, which are smaller than NeuroOne Medical Technologies Corp. quarterly revenues of $2.7M. Beyond Air, Inc.'s net income of -$8.3M is lower than NeuroOne Medical Technologies Corp.'s net income of -$1.6M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while NeuroOne Medical Technologies Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 3.25x versus 2.52x for NeuroOne Medical Technologies Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XAIRBeyond Air, Inc.3.25x -- $1.8M -$8.3M NMTCNeuroOne Medical Technologies Corp.2.52x -- $2.7M -$1.6M
-
Which has Higher Returns XAIR or NTRB?
Nutriband, Inc. has a net margin of -454.24% compared to Beyond Air, Inc.'s net margin of -1118.87%. Beyond Air, Inc.'s return on equity of -220.61% beat Nutriband, Inc.'s return on equity of -164.64%.
Company Gross Margin Earnings Per Share Invested Capital XAIRBeyond Air, Inc.-16.39% -$1.25 $24.9M NTRBNutriband, Inc.18.2% -$0.32 $7.8M -
What do Analysts Say About XAIR or NTRB?
Beyond Air, Inc. has a consensus price target of $10.33, signalling upside risk potential of 1323.32%. On the other hand Nutriband, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 230.4%. Given that Beyond Air, Inc. has higher upside potential than Nutriband, Inc., analysts believe Beyond Air, Inc. is more attractive than Nutriband, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XAIRBeyond Air, Inc.2 1 0 NTRBNutriband, Inc.1 0 0 -
Is XAIR or NTRB More Risky?
Beyond Air, Inc. has a beta of 0.341, which suggesting that the stock is 65.907% less volatile than S&P 500. In comparison Nutriband, Inc. has a beta of 1.840, suggesting its more volatile than the S&P 500 by 84.015%.
-
Which is a Better Dividend Stock XAIR or NTRB?
Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Nutriband, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. Nutriband, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XAIR or NTRB?
Beyond Air, Inc. quarterly revenues are $1.8M, which are larger than Nutriband, Inc. quarterly revenues of $346.1K. Beyond Air, Inc.'s net income of -$8.3M is lower than Nutriband, Inc.'s net income of -$3.9M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while Nutriband, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 3.25x versus 22.65x for Nutriband, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XAIRBeyond Air, Inc.3.25x -- $1.8M -$8.3M NTRBNutriband, Inc.22.65x -- $346.1K -$3.9M
-
Which has Higher Returns XAIR or NVNO?
enVVeno Medical Corp. has a net margin of -454.24% compared to Beyond Air, Inc.'s net margin of --. Beyond Air, Inc.'s return on equity of -220.61% beat enVVeno Medical Corp.'s return on equity of -57.7%.
Company Gross Margin Earnings Per Share Invested Capital XAIRBeyond Air, Inc.-16.39% -$1.25 $24.9M NVNOenVVeno Medical Corp.-- -$0.23 $30.2M -
What do Analysts Say About XAIR or NVNO?
Beyond Air, Inc. has a consensus price target of $10.33, signalling upside risk potential of 1323.32%. On the other hand enVVeno Medical Corp. has an analysts' consensus of $12.50 which suggests that it could grow by 3796.51%. Given that enVVeno Medical Corp. has higher upside potential than Beyond Air, Inc., analysts believe enVVeno Medical Corp. is more attractive than Beyond Air, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XAIRBeyond Air, Inc.2 1 0 NVNOenVVeno Medical Corp.0 1 0 -
Is XAIR or NVNO More Risky?
Beyond Air, Inc. has a beta of 0.341, which suggesting that the stock is 65.907% less volatile than S&P 500. In comparison enVVeno Medical Corp. has a beta of 1.040, suggesting its more volatile than the S&P 500 by 4.044%.
-
Which is a Better Dividend Stock XAIR or NVNO?
Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. enVVeno Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. enVVeno Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XAIR or NVNO?
Beyond Air, Inc. quarterly revenues are $1.8M, which are larger than enVVeno Medical Corp. quarterly revenues of --. Beyond Air, Inc.'s net income of -$8.3M is lower than enVVeno Medical Corp.'s net income of -$4.5M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while enVVeno Medical Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 3.25x versus 473.07x for enVVeno Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XAIRBeyond Air, Inc.3.25x -- $1.8M -$8.3M NVNOenVVeno Medical Corp.473.07x -- -- -$4.5M
-
Which has Higher Returns XAIR or SINT?
SINTX Technologies, Inc. has a net margin of -454.24% compared to Beyond Air, Inc.'s net margin of -1701.44%. Beyond Air, Inc.'s return on equity of -220.61% beat SINTX Technologies, Inc.'s return on equity of -208.36%.
Company Gross Margin Earnings Per Share Invested Capital XAIRBeyond Air, Inc.-16.39% -$1.25 $24.9M SINTSINTX Technologies, Inc.-31.73% -$3.46 $7.5M -
What do Analysts Say About XAIR or SINT?
Beyond Air, Inc. has a consensus price target of $10.33, signalling upside risk potential of 1323.32%. On the other hand SINTX Technologies, Inc. has an analysts' consensus of $12.25 which suggests that it could grow by 217.36%. Given that Beyond Air, Inc. has higher upside potential than SINTX Technologies, Inc., analysts believe Beyond Air, Inc. is more attractive than SINTX Technologies, Inc..
Company Buy Ratings Hold Ratings Sell Ratings XAIRBeyond Air, Inc.2 1 0 SINTSINTX Technologies, Inc.2 0 0 -
Is XAIR or SINT More Risky?
Beyond Air, Inc. has a beta of 0.341, which suggesting that the stock is 65.907% less volatile than S&P 500. In comparison SINTX Technologies, Inc. has a beta of 0.649, suggesting its less volatile than the S&P 500 by 35.053%.
-
Which is a Better Dividend Stock XAIR or SINT?
Beyond Air, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. SINTX Technologies, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Beyond Air, Inc. pays -- of its earnings as a dividend. SINTX Technologies, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios XAIR or SINT?
Beyond Air, Inc. quarterly revenues are $1.8M, which are larger than SINTX Technologies, Inc. quarterly revenues of $208K. Beyond Air, Inc.'s net income of -$8.3M is lower than SINTX Technologies, Inc.'s net income of -$3.5M. Notably, Beyond Air, Inc.'s price-to-earnings ratio is -- while SINTX Technologies, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Beyond Air, Inc. is 3.25x versus 6.55x for SINTX Technologies, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income XAIRBeyond Air, Inc.3.25x -- $1.8M -$8.3M SINTSINTX Technologies, Inc.6.55x -- $208K -$3.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 1
Corcept Therapeutics, Inc. [CORT] is down 50.44% over the past day.
Buy
75
AXSM alert for Jan 1
Axsome Therapeutics, Inc. [AXSM] is up 22.82% over the past day.
Buy
81
ZIJMY alert for Jan 1
Zijin Mining Group Co., Ltd. [ZIJMY] is up 1.86% over the past day.
